InMode Ltd (STU:154)
€ 16.81 0.21 (1.27%) Market Cap: 1.24 Bil Enterprise Value: 587.59 Mil PE Ratio: 9.22 PB Ratio: 1.77 GF Score: 64/100

Inmode Ltd at UBS Global Healthcare Virtual Conference Transcript

May 26, 2021 / 02:00PM GMT
Matthew Charles Taylor;Moshe Mizrahy
UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices;InMode

Okay. Good morning, and thanks for joining us for our next session here in the medtech track of the UBS Global Virtual Health Care Conference. And hopefully, it's the last time we have to use one of those prefaces. And I'm joined by management from InMode. It's an exciting growth company in the aesthetics space.

We have a number of members of the management team joining us here today including Moshe Mizrahy, the Chairman, CEO and Founder; also Dr. Michael Kreindel, who's the CTO and Co-Founder; Yair Malca, the CFO; Shakil Lakhani, the President of North America, the largest commercial organization for the company; and Dr. Spero Theodorou, the Chief Medical Officer. So we should be able to answer all of your questions. A great breadth of roles here and (inaudible) control.

So first of all, I just want to thank all of you guys for joining us. It's always a pleasure to speak with you, and welcome to the presentation.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot